Pamela P. Palmer
2012
In 2012, Pamela P. Palmer earned a total compensation of $1.1M as Chief Medical Officer at AcelRx Pharmaceuticals, a 13% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $134,034 |
|---|---|
| Option Awards | $544,991 |
| Salary | $396,550 |
| Total | $1,075,575 |
Palmer received $545K in option awards, accounting for 51% of the total pay in 2012.
Palmer also received $134K in non-equity incentive plan and $396.6K in salary.
Rankings
In 2012, Pamela P. Palmer's compensation ranked 5,843rd out of 11,487 executives tracked by ExecPay. In other words, Palmer earned more than 49.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,843 out of 11,487 | 49th |
Division Manufacturing | 2,070 out of 4,253 | 51st |
Major group Chemicals And Allied Products | 515 out of 1,198 | 57th |
Industry group Drugs | 350 out of 920 | 62nd |
Industry Pharmaceutical Preparations | 275 out of 700 | 61st |
Source: SEC filing on August 6, 2013.
Palmer's colleagues
We found four more compensation records of executives who worked with Pamela P. Palmer at AcelRx Pharmaceuticals in 2012.
News
AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
April 29, 2024
AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
August 28, 2023
AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
June 3, 2022
AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
April 24, 2020
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
May 14, 2019